Category: Life Sciences
Life Sciences market research reports by Plunkett Research, Ltd.
-
Financial Analysis and Multi-Year Benchmarking: Lyell Immunopharma Inc (LYEL:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Lyell Immunopharma Inc (LYEL:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Lyell Immunopharma Inc (LYEL:NAS). Includes Industry Averag ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Lumos Pharma Inc (LUMO:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Lumos Pharma Inc (LUMO:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Lumos Pharma Inc (LUMO:NAS). Includes Industry Averages & Top Com ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Ocugen Inc (OCGN:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Ocugen Inc (OCGN:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Ocugen Inc (OCGN:NAS). Includes Industry Averages & Top Competitors, KP ... Read More
-
Financial Analysis and Multi-Year Benchmarking: 60 Degrees Pharmaceuticals Inc (SXTP:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: 60 Degrees Pharmaceuticals Inc (SXTP:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: 60 Degrees Pharmaceuticals Inc (SXTP:NAS). Includes ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Turnstone Biologics Corp (TSBX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Turnstone Biologics Corp (TSBX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Turnstone Biologics Corp (TSBX:NAS). Includes Industry Av ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Royalty Pharma PLC (RPRX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Royalty Pharma PLC (RPRX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Royalty Pharma PLC (RPRX:NAS). Includes Industry Averages & Top ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Enanta Pharmaceuticals Inc (ENTA:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Enanta Pharmaceuticals Inc (ENTA:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Enanta Pharmaceuticals Inc (ENTA:NAS). Includes Industr ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Marinus Pharmaceuticals Inc (MRNS:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Marinus Pharmaceuticals Inc (MRNS:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Marinus Pharmaceuticals Inc (MRNS:NAS). Includes Indus ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Agios Pharmaceuticals Inc (AGIO:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Agios Pharmaceuticals Inc (AGIO:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Agios Pharmaceuticals Inc (AGIO:NAS). Includes Industry ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Ultragenyx Pharmaceutical Inc (RARE:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Ultragenyx Pharmaceutical Inc (RARE:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Ultragenyx Pharmaceutical Inc (RARE:NAS). Includes I ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Collegium Pharmaceutical Inc (COLL:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Collegium Pharmaceutical Inc (COLL:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Collegium Pharmaceutical Inc (COLL:NAS). Includes Ind ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Apellis Pharmaceuticals (APLS:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Apellis Pharmaceuticals (APLS:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Apellis Pharmaceuticals (APLS:NAS). Includes Industry Aver ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Ovid Therapeutics (OVID:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Ovid Therapeutics (OVID:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Ovid Therapeutics (OVID:NAS). Includes Industry Averages & Top C ... Read More
-
Financial Analysis and Multi-Year Benchmarking: RVL Pharmaceuticals PLC (RVLPQ:PINX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: RVL Pharmaceuticals PLC (RVLPQ:PINX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: RVL Pharmaceuticals PLC (RVLPQ:PINX). Includes Industry ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Zomedica Pharmaceuticals (ZOM:ASE). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Zomedica Pharmaceuticals (ZOM:ASE). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Zomedica Pharmaceuticals (ZOM:ASE). Includes Industry Aver ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Syros Pharmaceuticals (SYRS:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Syros Pharmaceuticals (SYRS:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Syros Pharmaceuticals (SYRS:NAS). Includes Industry Averages ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Tarsus Pharmaceuticals Inc (TARS:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Tarsus Pharmaceuticals Inc (TARS:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Tarsus Pharmaceuticals Inc (TARS:NAS). Includes Industr ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Xeris Pharmaceuticals Inc (XERS:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Xeris Pharmaceuticals Inc (XERS:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Xeris Pharmaceuticals Inc (XERS:NAS). Includes Industry ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Verrica Pharmaceuticals Inc (VRCA:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Verrica Pharmaceuticals Inc (VRCA:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Verrica Pharmaceuticals Inc (VRCA:NAS). Includes Indus ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Amylyx Pharmaceuticals Inc (AMLX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Amylyx Pharmaceuticals Inc (AMLX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Amylyx Pharmaceuticals Inc (AMLX:NAS). Includes Industr ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Natera Inc (NTRA:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Natera Inc (NTRA:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Natera Inc (NTRA:NAS). Includes Industry Averages & Top Competitors, KP ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Nuo Therapeutics Inc (AURX:PINX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Nuo Therapeutics Inc (AURX:PINX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Nuo Therapeutics Inc (AURX:PINX). Includes Industry Averages ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Accelerate Diagnostics Inc (AXDX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Accelerate Diagnostics Inc (AXDX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Accelerate Diagnostics Inc (AXDX:NAS). Includes Industr ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Zevra Therapeutics Inc (ZVRA:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Zevra Therapeutics Inc (ZVRA:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Zevra Therapeutics Inc (ZVRA:NAS). Includes Industry Averag ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Organon and Co (OGN:NYS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Organon and Co (OGN:NYS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Organon and Co (OGN:NYS). Includes Industry Averages & Top Competito ... Read More
Research Assistance
